Public Opinion

Promoting Basic Research in a New Age of Communications: Challenges and Opportunities


Low Percentage Hear About Clinical Trials from Health Care Providers

Op-ed by Abigail Schindler, PhD, postdoctoral fellow at the University of Washington, Department of Psychiatry and Behavioral Sciences and co-leader of the Seattle Forum on Science Ethics and Policy published in The Seattle Times.

Spain’€™s economy was harshly affected by the 2008 financial crisis and, later, the eurozone crisis.

Only Small Percentage say Health Care Professionals Have Ever Talked to Them about Medical Research

Dear Research Advocate:

A recent Gallup poll shows that Americans have an overall positive opinion of the work being done by two federal health agencies. The Centers for Disease Control and Prevention (CDC) was given a rating of ’€œgood’€ or ’€œexcellent’€ by 60 percent of respondents. The Food and Drug Administration (FDA) was given equally positive and fair ratings by 77 percent of those polled.

Dear Research Advocate,

The Food and Drug Administration, the oldest comprehensive consumer protection agency in the U.S. federal government, is charged with protecting the public health. Under this mandate, it regulates drugs and medical devices for their safety and effectiveness. But is it a failing mandate? It’€™s been argued that the FDA’€™s long and costly approval processes stifle innovation and keep life-changing treatments from the market. When it comes to public health, is it ever OK to sacrifice safety for speed?

The winners of The 2013 Communicator Awards were recently announced by the International Academy of the Visual Arts.  With over 6000 entries received from across the US and around the world, the Communicator Awards is the largest and most competitive awards program honoring the creative excellence for communications professionals.


Subscribe to RSS - Public Opinion